Keyuan Pharmaceutical Co., Ltd.

Announcement on Shareholding Changes of Shareholders Holding Over 5% and Their Concerted Actions

Announcement on the release of part of the pledged shares by shareholders holding more than 5%

Announcement on Participating in the 2026 Shandong Region Listed Companies Investor Online Collective Reception Day Activities

CITIC Jiantou Securities Co., Ltd. Tracking Report on Shandong Keyuan Pharmaceutical Co., Ltd. for the Year 2025

Legal Opinion from Beijing Deheng (Jinan) Law Firm Regarding the 2025 Annual Shareholders' Meeting of Shandong Keyuan Pharmaceutical Co., Ltd.

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

2026 Q1 Report

Pre-disclosure Announcement on the Share Reduction Plan of Shareholders Holding More Than 5%

Announcement on Proposing the Shareholders' Meeting to Authorize the Board of Directors to Handle Matters Related to Issuing Stocks to Specific Objects by Simplified Procedures

CITIC Construction Investment Securities Co., Ltd. Regular On-Site Inspection Report of Shandong Keyuan Pharmaceutical Co., Ltd. for the Year 2025

Announcement on the Proposal to Reappoint the Accounting Firm

2025 Board of Directors Work Report

Announcement on the Compensation Plan for Directors and Senior Management for the Year 2026

2025 Annual Report of Independent Directors (Dai Huiyu)

2025 Annual Report of Independent Directors (Li Wenming)

2025 Annual Report of Independent Directors (Jin Lina)

Announcement on Holding the 2025 Annual Performance Presentation

2025 Annual Environmental, Social, and Corporate Governance Report

CITIC Construction Investment Securities Co., Ltd. Verification Opinion on the 2025 Annual Self-Evaluation Report on Internal Control of Shandong Keyuan Pharmaceutical Co., Ltd.

Internal Control Audit Report of Shandong Keyuan Pharmaceutical Co., Ltd.

2025 Annual Self-Evaluation Report on Internal Control

2025 Annual Goodwill Impairment Test Report

Announcement on the Provision for Asset Impairment for the Year 2025

CITIC Construction Investment Securities Co., Ltd. Verification Opinion on the Temporary Use of Part of the Idle Raised Funds to Supplement Working Capital of Shandong Keyuan Pharmaceutical Co., Ltd.

Announcement on the Temporary Use of Part of the Idle Raised Funds to Supplement Working Capital

CITIC Construction Investment Securities Co., Ltd. Verification Opinion on Changes in Some Fundraising Investment Projects of Shandong Keyuan Pharmaceutical Co., Ltd.

Announcement on Changes in Fundraising Investment Projects

CITIC Construction Investment Securities Co., Ltd. Verification Opinion on the Confirmation of Daily Related Transactions for the Year 2025 and the Estimated Daily Related Transactions for the Year 2026 of Shandong Keyuan Pharmaceutical Co., Ltd.

Announcement on the Confirmation of Daily Related Transactions for the Year 2025 and the Estimated Daily Related Transactions for the Year 2026

Notice of the 2025 Annual Shareholders' Meeting

Announcement of Resolutions from the Twenty-First Meeting of the Fourth Board of Directors

Announcement on the Profit Distribution Plan for the Year 2025